March 31, 2025 |
OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of experience in medical affairs and scientific commercialization to his new role, where he will focus on refining and deploying an innovation and growth strategy.

March 31, 2025, London, UK – OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of experience in medical affairs and scientific commercialization to his new role, where he will focus on refining and deploying an innovation and growth strategy.
Before joining OPEN Health, he served as CEO of the Healthcare Consultancy Group (HCG), a medical communications business within Omnicom. During his tenure, he led enterprise client partnerships, expanded global teams, and developed market access strategies that helped drive consistent growth. Matt has also held agency leadership roles at Envision Communications and Syneos Health, and he cites a diverse set of oncology marketing and sales roles at AstraZeneca for shaping his approach to scientific commercialization.
“I am truly honored to lead OPEN Health at this time,” said Matt. “We have an incredible team, a strong foundation, and an unwavering commitment to providing services that play an important role in the translation of scientific complexity into clinical meaning, bringing medicine closer to patients in need.”
“Matt’s global experience, commitment to scientific excellence, and innovation mindset align perfectly with OPEN Health’s core values and growth strategy,” said Dave King, Chairman of OPEN Health’s Board of Directors. “We are confident that he will lead us to even greater heights, and we are excited for the future under his leadership.”
Matt succeeds Vivid Sehgal, Interim CEO, who will continue his journey with OPEN Health by joining the company’s board as a Non-Executive Director.
About OPEN Health
OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market access, scientific communications, patient engagement, and creative omnichannel communications. To learn more, visit www.openhealthgroup.com
Contact:
Candice Subero, VP of Global Marketing
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.
Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.
Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding...
OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health
OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.
OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.
OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical...
The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access
OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver
